Purchase Order 140D0426P0134

<p>The National Cancer Institute issued a purchase order to Yokogawa Corporation of America for $83,945.00 on May 15, 2026. Performance will be completed by May 14, 2027. The order is firm fixed price with no set-aside. Work is performed in Newnan, Georgia. Yokogawa, doing business as Dixon Industrial Sales, is a foreign-owned subsidiary of Yokogawa Electric Corporation and specializes in precision measurement and control equipment for federal research institutions.</p>

The National Cancer Institute (NCI) awarded a $14,670 purchase order to Yokogawa Corporation of America, doing business as Dixon Industrial Sales, for the purchase of a replacement OEM 40x water objective for a Yokogawa CV8000 high-content screening system. This firm fixed-price contract has an ultimate completion date of September 11, 2024 and does not have a set-aside designation. Yokogawa is a foreign-owned, for-profit manufacturer of specialized test and measurement equipment that has...

This firm-fixed-price purchase order, valued at $294,432.76, was awarded by the National Cancer Institute to Yokogawa Corp Of America, doing business as Dixon Industrial Sales, to provide maintenance and preventive maintenance services for the government-owned Yokogawa CV7000 and CV8000 high-throughput microscopy systems. The contract supports the President's Department Efficiency Cost Efficiency Initiative and has an ultimate completion date of September 19, 2025. The award was not set aside...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $507,279.00 firm fixed-price purchase order to Fujifilm Wako Automation Corporation, a foreign-owned for-profit company, to procure a Yokogawa CV8000 high-throughput microscopy system. The system will be used by the NCI Center for Cancer Research Laboratory of Receptor Biology and Gene Expression High-Throughput Imaging Facility. The award was not set aside and was made...

<p>The National Cancer Institute issued a delivery order to Global Life Sciences Solutions USA LLC on May 13, 2026, for supply of an Amersham Typhoon IP biomolecular imager, with a ceiling value of $64,769.64.</p> <p>Place of performance is Marlborough, MA. Ultimate completion date is December 31, 2026. This is a firm fixed-price delivery order issued under the Multiple Award Schedule (MAS), with no small business set-aside.</p>

The National Cancer Institute issued a delivery order to Government Scientific Source Inc., a small business, on September 15, 2020, with a ceiling value of $202,169.12 under the GSA Multiple Award Schedule (MAS) for the purchase of two Keyence BZ-X810 all-in-one fluorescence microscopes and associated instrumentation in support of the ETIB and CPTR labs at the NCI Center for Cancer Research. Place of performance is Reston, VA. The order carries a total small business set-aside designation and...

The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $68,735.42 on August 14, 2020, to procure one fluorescence microscope camera upgrade for a government-owned DeltaVision Elite microscope system. Work is performed at the contractor's facility in Marlborough, Massachusetts. The order carries firm fixed-price terms with an ultimate completion date of December 21, 2020. No set-aside designation was used. The procurement originated from a special...

<p>The National Cancer Institute issued a delivery order to Olympus America Inc. on August 5, 2020, with a ceiling value of $24,795.07 for scientific equipment, under the Multiple Award Schedule (MAS).</p> <p>Place of performance is Waltham, MA. The order has an ultimate completion date of September 30, 2020. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute issued a delivery order to Nikon Instruments Inc. on August 21, 2018, with a ceiling value of $10,561.55 for scientific equipment.</p> <p>Place of performance is Melville, NY. The order is firm fixed price and was completed by October 31, 2018. No set-aside was used.</p>

The National Cancer Institute, National Institutes of Health, awarded a purchase order to Sony Biotechnology Inc. for one Sony MA900 cell sorter valued at $353,798.40 on May 13, 2020. Place of performance is San Jose, California. The order supports the Center for Cancer Research, Lymphoid Malignancies Branch, and includes the cell sorter, associated equipment, supplies, installation, training for up to five users, and a minimum one-year warranty. Ultimate completion date is August 7, 2020. The...